Skip to content
DataLookout
Menu

ELSNCT04713722

Early Life Stress and Depression: Molecular and Functional Imaging

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 10 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 9 versions: 6 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Jun 30, 2026 to Apr 30, 2027
    • Eligibility criteria expanded, about 28 words
  2. Notable Primary and study completion dates: Apr 1, 2025 to Jun 30, 2026
    • Site contact updated
    v8
  3. Minor Site contact updatedv7
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 1, 2021 to Feb 1, 2021
    v3
  5. Minor Start date: Feb 1, 2021 to Mar 1, 2021v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Immuno-oxidative abnormalities
Timeframe: Baseline

Secondary (3)

Blood oxygen level dependent (BOLD) activation
Blood oxygen level dependent (BOLD) activation in emotional processing
Peripheral inflammation

Arms and interventions

MDD/childhood adversity group

subjects with current MDD who experienced childhood adversity

rMDD/ childhood adversity

subjects with a history of MDD who experienced childhood adversity

MDD

subjects in a current episode of MDD, with no history of childhood adversity

Healthy Control

healthy control subjects, with no history of childhood adversity

Sites

1 site in 1 country

  • McLean HospitalBelmont, Massachusetts, United States